Clinical trial

PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

NCT02805166

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE4

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2016-06-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malignant Solid Tumorsunresolved

Interventions

PEG-rhG-CSFDRUG

Sponsors & collaborators

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02805166 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.